https://news.augustaheadlines.com/story/413610/osteomyelitis-market-is-predicted-to-exhibit-remarkable-growth-during-the-forecast-period-20222032-analyzes-delveinsight-key-companies-durata-therapeutics-inc-basilea-pharmaceuticals.html 2023-03-23T11:34:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/413609/acuteonchronic-liver-failure-market-to-exhibit-moderate-growth-rate-during-the-forecast-period-20222032-investigates-delveinsight-key-companies-grifols-therapeutics-versantis-ag-hepastem.html 2023-03-23T11:32:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/413608/80-active-companies-working-to-develop-80-pipeline-therapies-for-biliary-tract-cancers-treatment.html 2023-03-23T11:28:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/413607/triple-negative-breast-cancer-pipeline-assessment-2023-insight-into-the-current-therapies-emerging-drugs-treatment-outlook-and-key-companies-hibercell-roche-infinity-pharmaceuticals-cytodyn.html 2023-03-23T11:24:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/413605/pulmonary-hypertension-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight.html 2023-03-23T11:20:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/413604/type-2-diabetes-clinical-trial-pipeline-analysis-insight-into-the-current-therapies-emerging-drugs-treatment-outlook-key-companies-astrazenca-hanmi-pharmaceuticals-and-others.html 2023-03-23T11:18:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/413603/100-active-companies-working-to-develop-100-pipeline-therapies-for-bladder-cancer-treatment.html 2023-03-23T11:16:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/413602/150-active-companies-working-to-develop-150-pipeline-therapies-for-colorectal-cancer-treatment.html 2023-03-23T11:14:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/413601/140-active-companies-working-to-develop-140-pipeline-therapies-for-metastatic-colorectal-cancer-treatment.html 2023-03-23T11:12:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/413600/230-active-companies-working-to-develop-230-pipeline-therapies-for-gastric-cancer-treatment.html 2023-03-23T11:10:03+00:00 daily 1.0